日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential

CNPY2 在内质网应激之外的多重作用:疾病意义和治疗潜力

Ebadollahibaruq, Shima; Meng, Lingbin; Hong, Feng

CNPY2 drives DSS-induced colitis via the macrophage-ROS axis.

CNPY2 通过巨噬细胞-ROS 轴驱动 DSS 诱导的结肠炎

Zhang Wenqing, Meng Lingbin, Zhang Xiaoli, Li Zihai, Hong Feng

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

克服去势抵抗性前列腺癌的耐药性:现有机制和新兴治疗方法

Khorasanchi, Adam; Hong, Feng; Yang, Yuanquan; Singer, Eric A; Wang, Peng; Li, Mingjia; Zheng, Linghua; Monk, Paul; Mortazavi, Amir; Meng, Lingbin

CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications

CNPY2在实体瘤中的作用机制、生物标志物潜力及治疗意义

Mullick Chowdhury, Sayan; Hong, Feng; Rolfo, Christian; Li, Zihai; He, Kai; Wesolowski, Robert; Mortazavi, Amir; Meng, Lingbin

Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer

评估高危前列腺癌患者放疗期间常用非肿瘤药物使用的影响

Perlow, Haley K; Khullar, Karishma; Kumar, Ritesh; Sasmal, Sonya; Nakamoto, Kent; Gokun, Yevgeniya; Eckstein, Jacob; Young, Rebekah; Diaz, Dayssy A; Martin, Douglas; Collier, Katharine A; Meng, Lingbin; Parikh, Rahul R; Clinton, Steven; Wang, Shang-Jui

Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis

酪氨酸激酶抑制剂在骨转移为主的肾细胞癌中疗效优于免疫检查点抑制剂:一项多中心真实世界分析

Meng, Lingbin; Psutka, Sarah P; Gheeya, Jinesh; Li, Mingjia; Noonavath, Meghana; Orcutt, Delaney; Gross, Evan; Collier, Katharine A; Mortazavi, Amir; Folefac, Edmund; Monk, Paul; Yang, Yuanquan

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies

早期急性肾损伤及其与接受一线免疫疗法治疗的转移性非小细胞肺癌患者生存率的关系

Li, Mingjia; Su, Po-Lan; Zhao, Songzhu; Cheng, Grace; Jones, Nicholas; Chian, Kenneth; Johns, Natalie; Khorasanchi, Adam; Adeluola, Adeoluwa; Petouhoff, Annastasia; Spakowicz, Daniel J; Wei, Lai; Wang, Xiaoying; Coss, Christopher; Phelps, Mitch A; Meng, Lingbin; Yang, Yuanquan; Meara, Alexa; Elsaid, Mohamed I; Gheeya, Jinesh; Roof, Logan; Alahmadi, Asrar; Memmott, Regan M; Kaufman, Jacob; He, Kai; Presley, Carolyn J; Shields, Peter G; Carbone, David P; Otterson, Gregory A; Prosek, Jason; Owen, Dwight H

Harnessing the power of combination therapy: reflecting on the final survival data from the CLEAR study with lenvatinib plus pembrolizumab

发挥联合疗法的优势:回顾 CLEAR 研究中乐伐替尼联合帕博利珠单抗的最终生存数据

Shinder, Brian M; Meng, Lingbin; Singer, Eric A

Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies

新辅助免疫疗法在泌尿生殖系统恶性肿瘤中的作用

Khorasanchi, Adam; Jatwani, Karan; Meng, Lingbin; Collier, Katharine A; Sundi, Debasish; Dason, Shawn; Singer, Eric A; Gopalakrishnan, Dharmesh; Mortazavi, Amir; Chatta, Gurkamal; Yang, Yuanquan

Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer

年龄与转移性结直肠癌患者治疗相关不良事件和生存率的关系

Meng, Lingbin; Thapa, Ram; Delgado, Maria G; Gomez, Maria F; Ji, Rui; Knepper, Todd C; Hubbard, Joleen M; Wang, Xuefeng; Permuth, Jennifer B; Kim, Richard D; Laber, Damian A; Xie, Hao